Latest Advances

  • Condition: Metastatic Neuroendocrine Tumors
  • Journal: World journal of gastroenterology
  • Treatment Used: 177Lu Peptide Receptor Radionuclide Therapy
  • Number of Patients: 36
  • Published —
The study researched the outcomes of 177Lu peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumors.
  • Condition: Metastatic Adult Pancreatoblastoma
  • Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
  • Treatment Used: Oxaliplatin Multimodal Treatment
  • Number of Patients: 4
  • Published —
This case report describes using various multimodal treatments to treat patients with metastatic adult pancreatoblastoma.
  • Condition: Gastroenteropancreatic Neuroendocrine Tumors
  • Journal: Journal of surgical oncology
  • Treatment Used: Adjuvant Therapy After Surgery
  • Number of Patients: 91
  • Published —
In this study, researchers evaluated the outcomes of having adjuvant therapy, including chemotherapy, after surgery to remove gastroenteropancreatic neuroendocrine tumors.
  • Condition: Gastroenteropancreatic Neuroendocrine Neoplasms
  • Journal: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology
  • Treatment Used: Various
  • Number of Patients: 192
  • Published —
This study sought to determine the best treatments for gastroenteropancreatic neuroendocrine tumors.
  • Condition: Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
  • Treatment Used: Palliative Resection
  • Number of Patients: 53
  • Published —
This study tested the safety and efficacy of using palliative resection to treat patients with advanced gastroenteropancreatic neuroendocrine tumors.
  • Condition: Gastroenteropancreatic Neuroendocrine Neoplasms
  • Journal: World journal of surgery
  • Treatment Used: Surgery
  • Number of Patients: 205
  • Published —
The study researched the outcomes and treatment of gastroenteropancreatic neuroendocrine neoplasms.
  • Condition: Neuroendocrine Tumors of the Gastroenteropancreatic System (GEP)
  • Journal: Deutsche medizinische Wochenschrift (1946)
  • Treatment Used: Systemic Therapy and Ablation
  • Number of Patients: 0
  • Published —
This article discusses novel aspects and developments in the diagnosis and treatment of neuroendocrine tumors
  • Condition: Elderly Patients with Distant Metastatic Pancreatic Neuroendocrine Tumor
  • Journal: Clinical interventions in aging
  • Treatment Used: Primary Site Surgery
  • Number of Patients: 210
  • Published —
The study researched the outcomes of primary site surgery in elderly patients with distant metastatic pancreatic neuroendocrine tumor.
  • Condition: Gastroenteropancreatic Neuroendocrine Tumors
  • Journal: Future oncology (London, England)
  • Treatment Used: Somatostatin Analogs in Association with Peptide Receptor Radionucleotide Therapy
  • Number of Patients: 0
  • Published —
This study evaluated data from 69 well-differentiated gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionucleotide therapy plus somatostatin analogs (SSAs) after somatostatin analogs treatment failure were evaluated.
  • Condition: Gastric and Duodenopancreatic Neuroendocrine Tumor
  • Journal: World journal of surgery
  • Treatment Used: Surgical Resection
  • Number of Patients: 24
  • Published —
This study tested the safety and efficacy of using surgical resections to eliminate gastric and duodenopancreatic neuroendocrine tumors.
  • Condition: Well-differentiated Pancreatic Neuroendocrine Tumor (PanNET) in a Patient With Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM)
  • Journal: The American journal of surgical pathology
  • Treatment Used: Surgical Resection
  • Number of Patients: 1
  • Published —
This case report discusses a patient with familial atypical multiple mole melanoma syndrome (FAMMM) diagnosed with a a well-differentiated pancreatic neuroendocrine tumor (PanNET) treated with surgical resection.
  • Condition: Concurrent Adult-Onset Diffuse ?-Cell Nesidioblastosis and Pancreatic Neuroendocrine Tumor
  • Journal: International journal of surgical pathology
  • Treatment Used: Completion Pancreatectomy
  • Number of Patients: 1
  • Published —
This case report describes a 49-year-old woman with concurrent adult-onset diffuse b-Cell nesidioblastosis and pancreatic neuroendocrine tumor treated with completion pancreatectomy.
Showing 1-12 of 34